<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Model Gateway: Model Management Platform for Model-Driven Drug Discovery - Health AI Hub</title>
    <meta name="description" content="The Model Gateway is a management platform designed for machine learning (ML) and scientific computational models within the drug discovery pipeline. It integra">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>Model Gateway: Model Management Platform for Model-Driven Drug Discovery</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2512.05462v1" target="_blank">2512.05462v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-12-05
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Yan-Shiun Wu, Nathan A. Morin
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> cs.SE, cs.DC, cs.LG, q-bio.QM
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 0.95 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2512.05462v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2512.05462v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">The Model Gateway is a management platform designed for machine learning (ML) and scientific computational models within the drug discovery pipeline. It integrates Large Language Model (LLM) Agents and Generative AI tools to automate MLOps tasks such as model registration, execution, and dynamic consensus. This platform aims to significantly accelerate model-driven drug discovery by providing a scalable and reliable infrastructure for model management.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>This platform is highly relevant to medicine and health because it directly addresses the inefficiency in managing computational models crucial for drug discovery. By accelerating the identification and development of new therapeutic candidates, it can significantly shorten the timeline for bringing life-saving drugs to patients.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>The Model Gateway is an AI-powered (ML, LLM Agents, Generative AI) platform designed to manage and accelerate the complex computational models used in drug discovery pipelines, thereby speeding up the development of new therapeutic drugs.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>**Comprehensive Model Management:** Provides a dedicated platform for managing diverse ML and scientific computational models used in drug discovery.</li>
                    
                    <li>**AI-Powered MLOps Integration:** Leverages LLM Agents and Generative AI tools to enhance and automate various ML Operations (MLOps) tasks, streamlining model lifecycle management.</li>
                    
                    <li>**Core Functional Capabilities:** Supports essential tasks including dynamic consensus model aggregation, model registration/management, detailed information retrieval, asynchronous model submission/execution, and efficient result delivery.</li>
                    
                    <li>**Robust Architectural Components:** Comprises a Model Owner Control Panel, Platform Admin Tools, and a Model Gateway API service for robust interaction, management, and tracking of model execution.</li>
                    
                    <li>**Exceptional Scalability and Reliability:** Demonstrated a 0% failure rate when tested with over 10,000 simultaneous application clients, proving its capability to handle high demand.</li>
                    
                    <li>**Foundational for Model-Driven Discovery:** Serves as a fundamental part of a model-driven drug discovery pipeline, enabling the efficient deployment and utilization of computational models.</li>
                    
                    <li>**Accelerated Drug Development Potential:** Has the potential to significantly accelerate new drug development through mature MLOps infrastructure and advanced AI integration, contributing to faster time-to-market for therapeutics.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>The paper presents the design and architecture of the Model Gateway platform, detailing its components and capabilities. The methodology involved the integration of LLM Agents and Generative AI for automating MLOps tasks. Performance and reliability were evaluated through stress testing, demonstrating its scalability by simulating consumption by over 10,000 simultaneous application clients.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>The Model Gateway is a highly effective and scalable platform for managing ML and scientific computational models in drug discovery, successfully integrating LLM Agents and Generative AI. A key finding is its robust performance, achieving a 0% failure rate even when scaling beyond 10,000 simultaneous client applications, establishing it as a foundational and reliable component for model-driven drug discovery.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>By drastically speeding up the drug discovery process through efficient model management and advanced AI integration, the Model Gateway can lead to a quicker identification of promising drug candidates. This translates to reduced development costs, faster access to novel treatments for patients, and improved outcomes across various diseases, ultimately benefiting public health.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The abstract does not explicitly state limitations but implies that the full realization of the platform's potential is contingent upon the continued "maturity of our MLOps infrastructure and the integration of LLM Agents and Generative AI tools," suggesting ongoing development is crucial.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>Future efforts will focus on further maturing the MLOps infrastructure and deepening the integration and capabilities of LLM Agents and Generative AI tools within the Model Gateway to maximize its potential in accelerating drug development.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Pharmaceutical Research</span>
                    
                    <span class="tag">Drug Discovery</span>
                    
                    <span class="tag">Computational Biology</span>
                    
                    <span class="tag">Medicinal Chemistry</span>
                    
                    <span class="tag">Bioinformatics</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Drug Discovery</span>
                    
                    <span class="tag tag-keyword">MLOps</span>
                    
                    <span class="tag tag-keyword">Model Management</span>
                    
                    <span class="tag tag-keyword">Machine Learning</span>
                    
                    <span class="tag tag-keyword">Generative AI</span>
                    
                    <span class="tag tag-keyword">LLM Agents</span>
                    
                    <span class="tag tag-keyword">Computational Models</span>
                    
                    <span class="tag tag-keyword">Scalability</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">This paper presents the Model Gateway, a management platform for managing machine learning (ML) and scientific computational models in the drug discovery pipeline. The platform supports Large Language Model (LLM) Agents and Generative AI-based tools to perform ML model management tasks in our Machine Learning operations (MLOps) pipelines, such as the dynamic consensus model, a model that aggregates several scientific computational models, registration and management, retrieving model information, asynchronous submission/execution of models, and receiving results once the model complete executions. The platform includes a Model Owner Control Panel, Platform Admin Tools, and Model Gateway API service for interacting with the platform and tracking model execution. The platform achieves a 0% failure rate when testing scaling beyond 10k simultaneous application clients consume models. The Model Gateway is a fundamental part of our model-driven drug discovery pipeline. It has the potential to significantly accelerate the development of new drugs with the maturity of our MLOps infrastructure and the integration of LLM Agents and Generative AI tools.</p>
            </section>

            
            <section class="paper-section">
                <h2>Comments</h2>
                <p>7 pages, 7 figures</p>
            </section>
            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>